For the Inventor, By the Inventor

Enter assignee name

Leiden, Netherlands

Academisch Ziekenhuis Leiden

USPTO Granted Patents = 47

EPO Patents = 41

Forward Citations = 937

Loading Chart...

Loading Chart...

91 inventors (with patents filed for the assignee):

Judith Christina Theodora Van Deutekom (13 out of 23 patents)

Garrit-Jan Boudewijn Van Ommen (11 out of 19 patents)

Annemieke Aartsma-Rus (9 out of 12 patents)

4. Josephus Johannes De Kimpe (6 out of 15 patents)

5. Gerard Johannes Platenburg (5 out of 16 patents)

6. Daniël Verhoef (4 out of 4 patents)

7. Mettine H A Bos (4 out of 4 patents)

8. Cornelis Johannes Maria Melief (4 out of 15 patents)

9. Sjoerd Hendrikus Van Der Burg (4 out of 4 patents)

10. Annemieke Geluk (4 out of 4 patents)

11. Maria Johanna Philomena Schoenmaekers-Welters (4 out of 4 patents)

12. Annemieke M De Jong (4 out of 4 patents)

13. Rienk Offringa (4 out of 8 patents)

14. Johannes Theodorus Den Dunnen (4 out of 4 patents)

15. Pieter Hendrik Reitsma (4 out of 12 patents)

Core Competencies:

Prohemostatic Proteins

Peptide-Containing Adjuvants

Tissue Engineering

Ataxin 3 Modulation

Exon Skipping Techniques

Cardiac Event Biomarkers

Endothelial Cell Differentiation

Antigen Specific Immune Responses

Antisense Oligonucleotides

Genetic Disease Intervention

Antimicrobial Peptides

Enzyme-Prodrug Therapy

47 patents: Sort by Forward Citations

1. 12083170 - Prohemostatic proteins for the treatment of bleeding (2024-09-10),

2. 12016918 - Peptide-containing adjuvant compounds having peg spacers (2024-06-25),

3. 11459358 - Substances for targeting various selected organs or tissues (2022-10-04),

4. 11357836 - Prohemostatic proteins for the treatment of bleeding (2022-06-14),

5. 11304995 - Prohemostatic proteins for the treatment of bleeding (2022-04-19),

6. 11293025 - Compositions and methods for modulating Ataxin 3 expression (2022-04-05),

7. 11208657 - Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure (2021-12-28),

8. RE48468 - Means and methods for counteracting muscle disorders (2021-03-15),

9. 10933163 - In situ tissue engineering (2021-03-02),

10. 10876114 - Methods and means for efficient skipping of at least one of the following exons of the human Duchenne muscular dystrophy gene: 43, 46, 50-53 (2020-12-29),

11. 10746745 - Future cardiac event biomarkers CCL3, CCL5, and CCL18 (2020-08-18),

12. 10544416 - Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA structure (2020-01-28),

13. 10537618 - Prohemostatic proteins for the treatment of bleeding (2020-01-21),

14. 10533175 - Compositions and methods for modulating Ataxin 3 expression (2020-01-14),

15. 10253073 - Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses (2019-04-09),

Academisch Ziekenhuis Leiden (Leiden University Medical Center), commonly known as LUMC, is a renowned academic medical center located in Leiden, the Netherlands. It is affiliated with Leiden University and serves as a teaching hospital for medical students. LUMC focuses on patient care, research, and education in various medical disciplines, playing a significant role in advancing healthcare and medical knowledge. The center's website provides comprehensive information about their services, medical research, faculty, and important developments in healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

47 Patents

#4 in Leiden

#174 in Netherlands

#14,414 in the World

Leiden, Netherlands

Academisch Ziekenhuis Leiden

Forward Citations = 937

91 inventors:

Judith Christina Theodora Van Deutekom (13 out of 23 patents)

Garrit-Jan Boudewijn Van Ommen (11 out of 19 patents)

Annemieke Aartsma-Rus (9 out of 12 patents)

4. Josephus Johannes De Kimpe (6 out of 15 patents)

5. Gerard Johannes Platenburg (5 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…